American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
The Honest Company
HNST
$540M
| $325K | ﹤0.01% |
111,141
+32,586
| +41% | +$96.9K |
|
|
SEM
2552
DELISTED
Select Medical
SEM
| $324K | ﹤0.01% |
+17,164
| New | +$293K |
|
2553
Kymera Therapeutics
KYMR
$9.51B
| $324K | ﹤0.01% |
10,847
-36,820
| -77% | -$1.27M |
|
2554
Blackbaud
BLKB
$2.1B
| $323K | ﹤0.01% |
4,245
-603
| -12% | -$46.5K |
|
2555
Silgan Holdings
SLGN
$4.46B
| $323K | ﹤0.01% |
7,626
+36
| +0.5% | +$1.67K |
|
2556
Jasper Therapeutics
JSPR
$28.7M
| $322K | ﹤0.01% |
14,204
+3,032
| +27% | +$72.7K |
|
2557
Brown-Forman Class A
BF.A
$13.1B
| $322K | ﹤0.01% |
7,299
+289
| +4% | +$13.8K |
|
2558
Telos
TLS
$344M
| $322K | ﹤0.01% |
79,988
+8,229
| +11% | +$31.2K |
|
2559
Ribbon Communications
RBBN
$377M
| $321K | ﹤0.01% |
97,718
+1,962
| +2% | +$5.97K |
|
2560
Arcos Dorados Holdings
ARCO
$1.71B
| $320K | ﹤0.01% |
35,567
-92,824
| -72% | -$955K |
|
2561
PepGen
PEPG
$206M
| $320K | ﹤0.01% |
20,028
+3,326
| +20% | +$47.7K |
|
|
FLG
2562
Flagstar Bank National Association
FLG
$5.92B
| $319K | ﹤0.01% |
+33,023
| New | +$319K |
|
2563
Vivid Seats
SEAT
$80.5M
| $318K | ﹤0.01% |
2,762
+518
| +23% | +$56.3K |
|
2564
Tenaya Therapeutics
TNYA
$164M
| $317K | ﹤0.01% |
102,114
+22,146
| +28% | +$91.5K |
|
2565
Inogen
INGN
$154M
| $314K | ﹤0.01% |
38,627
+9,626
| +33% | +$74.5K |
|
2566
Codexis
CDXS
$175M
| $312K | ﹤0.01% |
100,734
+16,019
| +19% | +$51.4K |
|
2567
Rush Street Interactive
RSI
$2.85B
| $311K | ﹤0.01% |
+32,406
| New | +$259K |
|
2568
CAVA Group
CAVA
$8.43B
| $309K | ﹤0.01% |
+3,335
| New | +$257K |
|
2569
COPT Defense Properties
CDP
$4.23B
| $309K | ﹤0.01% |
12,344
| – | – |
|
|
TSVT
2570
DELISTED
2seventy bio
TSVT
| $308K | ﹤0.01% |
79,953
+11,363
| +17% | +$51.2K |
|
2571
Erasca
ERAS
$6.25B
| $308K | ﹤0.01% |
130,407
+47,917
| +58% | +$103K |
|
2572
Tactile Systems Technology
TCMD
$537M
| $307K | ﹤0.01% |
25,711
+9,608
| +60% | +$129K |
|
2573
Rush Enterprises Class B
RUSHB
$9.37B
| $307K | ﹤0.01% |
7,815
-136
| -2% | -$5.88K |
|
|
ENFN
2574
DELISTED
Enfusion, Inc.
ENFN
| $306K | ﹤0.01% |
35,897
+5,253
| +17% | +$48.1K |
|
|
HI
2575
DELISTED
Hillenbrand
HI
| $306K | ﹤0.01% |
7,641
-1,531
| -17% | -$69.1K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.